Shares of Cardiovascular Systems, Inc. (NASDAQ:CSII) have been assigned a consensus rating of “Buy” from the nine analysts that are covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation, four have given a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $34.40.
A number of research analysts have recently commented on CSII shares. Needham & Company LLC reissued a “buy” rating and set a $32.00 price objective on shares of Cardiovascular Systems in a report on Tuesday, April 18th. BidaskClub raised Cardiovascular Systems from a “hold” rating to a “buy” rating in a report on Friday, June 9th. TheStreet raised Cardiovascular Systems from a “d” rating to a “c-” rating in a report on Thursday, May 4th. Finally, Bank of America Corporation lowered Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a report on Wednesday, June 21st.
ILLEGAL ACTIVITY WARNING: This piece of content was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The legal version of this piece of content can be viewed at https://www.com-unik.info/2017/07/17/cardiovascular-systems-inc-csii-receives-34-40-consensus-pt-from-analysts.html.
Hedge funds have recently added to or reduced their stakes in the stock. AQR Capital Management LLC acquired a new stake in Cardiovascular Systems during the fourth quarter worth about $736,000. State Street Corp raised its stake in Cardiovascular Systems by 5.7% in the fourth quarter. State Street Corp now owns 587,786 shares of the medical device company’s stock worth $14,229,000 after buying an additional 31,449 shares during the period. Teachers Advisors LLC raised its stake in Cardiovascular Systems by 62.1% in the fourth quarter. Teachers Advisors LLC now owns 95,895 shares of the medical device company’s stock worth $2,322,000 after buying an additional 36,735 shares during the period. Teachers Retirement System of The State of Kentucky acquired a new stake in Cardiovascular Systems during the fourth quarter worth about $631,000. Finally, NJ State Employees Deferred Compensation Plan acquired a new stake in Cardiovascular Systems during the first quarter worth about $424,000. 75.83% of the stock is currently owned by hedge funds and other institutional investors.
Cardiovascular Systems (CSII) traded down 0.12% during trading on Friday, reaching $32.40. The company had a trading volume of 120,434 shares. The stock has a 50 day moving average of $31.22 and a 200-day moving average of $28.18. Cardiovascular Systems has a 12 month low of $18.67 and a 12 month high of $33.11. The company’s market capitalization is $1.06 billion.
Cardiovascular Systems (NASDAQ:CSII) last issued its quarterly earnings data on Wednesday, May 3rd. The medical device company reported ($0.05) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.05). The business had revenue of $52.10 million for the quarter, compared to analyst estimates of $51.13 million. Cardiovascular Systems had a negative return on equity of 4.36% and a negative net margin of 3.72%. The firm’s revenue for the quarter was up 17.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted ($0.31) EPS. Equities research analysts expect that Cardiovascular Systems will post ($0.13) EPS for the current fiscal year.
About Cardiovascular Systems
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
What are top analysts saying about Cardiovascular Systems Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cardiovascular Systems Inc. and related companies.